Literature DB >> 25524739

Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.

Xiao Xiao1, Chaoqun Huang1, Chunling Zhao2, Xuxu Gou1, Lakmini K Senavirathna1, Myron Hinsdale1, Pamela Lloyd1, Lin Liu3.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is one of the most common and severe interstitial lung diseases. Epithelial-to-mesenchymal transition (EMT) is a process whereby epithelial cells undergo transition to a mesenchymal phenotype. This process has been shown to contribute to IPF. MicroRNAs (miRNAs) are small non-coding RNAs of 18-24 nucleotides in length which regulate gene expression. Several studies have implicated miRNAs in EMT; however, specific miRNAs that regulate EMT in IPF have not yet been identified. In this study, we identified 6 up-regulated and 3 down-regulated miRNAs in a human lung epithelial cell EMT model using miRNA microarray and real-time PCR. Overexpression of one of these up-regulated miRNAs, miR-424, increased the expression of α-smooth muscle actin, an indicator of myofibroblast differentiation, but had no effects on the epithelial or mesenchymal cell markers. miR-424 enhanced the activity of the TGF-β signaling pathway, as demonstrated by a luciferase reporter assay. Further experiments showed that miR-424 decreased the protein expression of Smurf2, a negative regulator of TGF-β signaling, indicating that miR-424 exerts a forward regulatory loop in the TGF-β signaling pathway. Our results suggest that miR-424 regulates the myofibroblast differentiation during EMT by potentiating the TGF-β signaling pathway, likely through Smurf2.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelial-to-mesenchymal transition; Idiopathic pulmonary fibrosis; Myofibroblast differentiation; Smurf2; TGF-β; miR-424

Mesh:

Substances:

Year:  2014        PMID: 25524739      PMCID: PMC4297572          DOI: 10.1016/j.abb.2014.12.007

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  77 in total

1.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase.

Authors:  Y Zhang; C Chang; D J Gehling; A Hemmati-Brivanlou; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.

Authors:  P Kavsak; R K Rasmussen; C G Causing; S Bonni; H Zhu; G H Thomsen; J L Wrana
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

Review 3.  microRNA: a master regulator of cellular processes for bioengineering systems.

Authors:  Wei Sun; Yi-Shuan Julie Li; Hsien-Da Huang; John Y-J Shyy; Shu Chien
Journal:  Annu Rev Biomed Eng       Date:  2010-08-15       Impact factor: 9.590

Review 4.  Epithelial-mesenchymal interactions in pulmonary fibrosis.

Authors:  Harold A Chapman
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

Review 5.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

6.  Alpha-smooth muscle actin expression upregulates fibroblast contractile activity.

Authors:  B Hinz; G Celetta; J J Tomasek; G Gabbiani; C Chaponnier
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

7.  Inhibition and role of let-7d in idiopathic pulmonary fibrosis.

Authors:  Kusum V Pandit; David Corcoran; Hanadie Yousef; Manohar Yarlagadda; Argyris Tzouvelekis; Kevin F Gibson; Kazuhisa Konishi; Samuel A Yousem; Mandal Singh; Daniel Handley; Thomas Richards; Moises Selman; Simon C Watkins; Annie Pardo; Ahmi Ben-Yehudah; Demosthenes Bouros; Oliver Eickelberg; Prabir Ray; Panayiotis V Benos; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2010-04-15       Impact factor: 21.405

Review 8.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

9.  miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Jadranka Milosevic; Qiang Ding; Victor J Thannickal; Naftali Kaminski; Edward Abraham
Journal:  J Exp Med       Date:  2010-07-19       Impact factor: 14.307

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

View more
  27 in total

1.  miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.

Authors:  Duo Li; Ke Liu; Zhiyong Li; Jian Wang; Xiaofeng Wang
Journal:  Cell Adh Migr       Date:  2017-11-13       Impact factor: 3.405

2.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

3.  Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis.

Authors:  Chaoqun Huang; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Xuxu Gou; Roshini Sathiaseelan; Lakmini Kumari Senavirathna; Pengcheng Wang; Lin Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2020-04       Impact factor: 6.914

Review 4.  The code of non-coding RNAs in lung fibrosis.

Authors:  Huachun Cui; Na Xie; Victor J Thannickal; Gang Liu
Journal:  Cell Mol Life Sci       Date:  2015-05-31       Impact factor: 9.261

5.  Genome-wide integration of microRNA and transcriptomic profiles of differentiating human alveolar epithelial cells.

Authors:  Alessandra Castaldi; Masafumi Horie; Megan E Rieger; Mickael Dubourd; Mitsuhiro Sunohara; Kusum Pandit; Beiyun Zhou; Ite A Offringa; Crystal N Marconett; Zea Borok
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-20       Impact factor: 5.464

6.  H. sinensis mycelium inhibits epithelial-mesenchymal transition by inactivating the midkine pathway in pulmonary fibrosis.

Authors:  Li Lu; Haiyan Zhu; Hailin Wang; Huaping Liang; Yayi Hou; Huan Dou
Journal:  Front Med       Date:  2021-04-27       Impact factor: 4.592

7.  Functionally engineered extracellular vesicles improve bone regeneration.

Authors:  Chun-Chieh Huang; Miya Kang; Yu Lu; Sajjad Shirazi; Jose Iriarte Diaz; Lyndon F Cooper; Praveen Gajendrareddy; Sriram Ravindran
Journal:  Acta Biomater       Date:  2020-04-16       Impact factor: 8.947

8.  MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.

Authors:  Chaoqun Huang; Xiao Xiao; Ye Yang; Amorite Mishra; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Michael R Blackburn; Craig A Henke; Lin Liu
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

9.  Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.

Authors:  Huaiqi Yao; Xuanzhi Liu; Suzuan Chen; Wei Xia; Xiaojun Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.

Authors:  Yapei Huang; Yan Xie; Peter W Abel; Peng Wei; Jocelyn Plowman; Myron L Toews; Heather Strah; Aleem Siddique; Kristina L Bailey; Yaping Tu
Journal:  Biochem Pharmacol       Date:  2020-07-24       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.